Inside the race to find a coronavirus vaccine

The article dives into some of the factors that may affect global access to the vaccine, once a viable candidate has been developed. Alex Kong explains that companies who are exploring medicines that can be repurposed for COVID-19 can be a positive thing "as governments are also more likely to allow trials for medicines already in use or under investigation." Alex also talks about some of the potential hurdles to consider early on such as supply shortages and stockouts - especially for low- and middle-income countries.